Para su Difusión
FTC Approves Final Order Preserving Competition in the U.S. Markets for Generic Drugs to Treat Certain Types of Ulcers, and Thyroid Conditions
Fecha
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the $8 billion merger between Endo International plc and Par Pharmaceuticals, Inc...